Companies that sell nicotine replacement therapy will no longer be required by the FDA to place warning labels on their products. The warning labels, which were mandated during the infancy of the products nearly 30 years ago, were found to contain errors pertaining to duration of use and dependence. A rare glimpse of the FDA admitting they were wrong.

Read the story.